Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Rockwell Collins Q3 Profit From Cont. Ops. Rises - Quick Facts

Rockwell Collins, Inc. (COL: Quote) reported third-quarter income from continuing operations of $163 million or $1.19 per share, compared to $161 million or $1.18 per share, in the third quarter of last year. Total earnings per share was $1.15, compared to $1.20.

On average, 19 analysts polled by Thomson Reuters expected the company to report profit per share of $1.17 for the quarter. Analysts' estimates typically exclude special items.

Total sales were $1.26 billion, an increase of 12% from $1.13 billion in the same period in 2013, primarily due to the acquisition of ARINC. Analysts expected revenue of $1.30 billion for the quarter.

The company also announced it entered into an agreement to sell its satellite communications systems business formerly known as Datapath, Inc., which designs, manufactures and services ground-based satellite communication systems primarily for military customers.

The company updated its fiscal year 2014 outlook from continuing operations due to the pending sale of Datapath and to narrow the ranges from the previous financial guidance.

Total sales are expected to be between $4.90 billion to $4.95 billion, compared to prior guidance range of $4.95 billion to $5.05 billion. Earnings per share is expected to be between $4.45 and $4.55, compared to previous guidance of $4.40 to $4.55. Analysts expect the company to report full year profit per share $4.50 on revenue of $5.04 billion.

Register
To receive FREE breaking news email alerts for Rockwell Collins and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
European stocks are seen opening lower on Monday, tracking weak commodity prices and a subdued trend across the Asia-Pacific region as investors look ahead to Chinese manufacturing data due on Tuesday for important clues about China's growth outlook. China is experiencing stable growth and there... Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The... Stocks showed a lack of direction over the course of the trading day on Friday after failing to sustain an initial upward move. Despite the choppy trading, the Dow once again managed to end the session at a new record closing high. The major averages turned in a mixed performance on the day.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.